Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening.
about
Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptorIdentification of xenoestrogens in food additives by an integrated in silico and in vitro approachThree-dimensional compound comparison methods and their application in drug discoveryDocking for fragment inhibitors of AmpC -lactamaseUnderstanding functional residues of the cannabinoid CB1.Applying DEKOIS 2.0 in structure-based virtual screening to probe the impact of preparation procedures and score normalizationFunction-specific virtual screening for GPCR ligands using a combined scoring methodUnraveling the structure and function of G protein-coupled receptors through NMR spectroscopy.Ligand discovery from a dopamine D3 receptor homology model and crystal structureMS-DOCK: accurate multiple conformation generator and rigid docking protocol for multi-step virtual ligand screening.The use of G-protein coupled receptor models in lead optimization.Therapeutic strategies underpinning the development of novel techniques for the treatment of HIV infection.Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in miceStructural Analysis of Chemokine Receptor-Ligand Interactions.Virtual screening of chemical libraries for drug discovery.Enhanced replication of R5 HIV-1 isolates in vitro by a small-molecule reagent targeting HIV-1 protease.Time-resolved magnetic resonance angiography: evaluation of intrapulmonary circulation parameters in pulmonary arterial hypertension.Integrated computational tools for identification of CCR5 antagonists as potential HIV-1 entry inhibitors: homology modeling, virtual screening, molecular dynamics simulations and 3D QSAR analysis.Allosteric model of maraviroc binding to CC chemokine receptor 5 (CCR5).Structure-based ligand discovery for the protein-protein interface of chemokine receptor CXCR4On the applicability of GPCR homology models to computer-aided drug discovery: a comparison between in silico and crystal structures of the beta2-adrenergic receptor.Virtual screening for novel COX-2 inhibitors using the ZINC databaseDiscovery of novel agonists and antagonists of the free fatty acid receptor 1 (FFAR1) using virtual screening.Chemokine receptors and other G protein-coupled receptors.Ligand and structure-based methodologies for the prediction of the activity of G protein-coupled receptor ligandsPharmacological modulation of chemokine receptor function.Identifying and characterizing promiscuous targets: implications for virtual screening.Expanding the horizons of G protein-coupled receptor structure-based ligand discovery and optimization using homology models.Using Spherical Harmonic Surface Property Representations for Ligand-Based Virtual Screening.Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment.Computational modeling of human coreceptor CCR5 antagonist as a HIV-1 entry inhibitor: using an integrated homology modeling, docking, and membrane molecular dynamics simulation analysis approach.Maximal Unbiased Benchmarking Data Sets for Human Chemokine Receptors and Comparative Analysis.Structure-Based Discovery of Allosteric Modulators of Two Related Class B G-Protein-Coupled ReceptorsRecent Trends and Applications of Molecular Modeling in GPCR⁻Ligand Recognition and Structure-Based Drug Design
P2860
Q24633082-281A120F-0112-47B0-81DA-F69986CC5343Q24656051-26D8B9BF-CD48-40E9-9924-8C4A1C5B020FQ26801796-71AB0E91-FFA5-4608-9915-98FCB10E43AFQ27655382-6CC62318-67C4-4007-A74B-759A701928D2Q27687653-AEE4D1C4-2770-42FC-84F7-4E6F1B985334Q27902289-E6A7B622-8DE1-4844-A92A-E580818D9E25Q28276613-8C12B9E9-3DCC-4FD8-8201-BBD9CAB15DBEQ30383769-5207CA61-92B3-402F-AE8E-A6D2D00B3E54Q31031038-E3447981-BDED-4A33-9F58-29147F1AC1FDQ33327574-7A138521-7C8B-4B04-AA21-7FBA46FECD03Q33893103-A8B4CA7D-FDD9-46BD-B629-D3FC929C4055Q34021729-357636EF-F628-4B6A-A2E8-1A730D41C879Q34179450-F9E96254-812F-4F0E-8AA8-FDFC7B1E427CQ34550666-9E85D694-896A-4204-8BD5-FD4310AC6602Q34626368-1E991670-E894-4B0F-92C2-5A8360D3A6ADQ34627166-40757033-DEE2-420A-BC13-5DDE3EC229C4Q34690025-89FFEBC5-2028-4C0E-872D-6670C0AA2054Q35156844-02DBF51A-84E8-46A1-8FB1-89E8481B3757Q35312348-652A5AF6-8D49-4BDB-B30B-A915DF7A2B0CQ35887252-BA792D30-2791-4D8C-B21A-84ED7D06DCEEQ36744266-8ABA6D1F-CD85-4816-A4BC-5F0E49358D00Q36782566-EDCC14F8-4DD4-449C-A61C-4746BEB349AEQ37013424-77709E9F-BF53-4AA6-96D8-F3C20F99E489Q37429729-4C79394D-8F43-4C05-AB2E-CA1B1D263C96Q37464148-670CE7A1-7D8F-47FB-BC56-D000910A6C1CQ37893687-A88FB12C-811B-4850-A7FC-83183218A30EQ37999084-BB1EAB7B-1283-42AF-85B7-ABC563EF5DC9Q38976083-4109DF15-B69B-4440-822D-1EC10C225AAAQ39551490-5902778B-E6AB-4B04-B68D-A325AE658AEEQ42863821-966718FF-F904-4F47-8BDC-FB1EBE32DFE6Q46477869-6AE83385-689A-4091-8241-08290290B27CQ53281795-DA9E269D-7840-4264-8FA7-D9C5D560DBFAQ56991997-3C10C79B-5DFD-4BC1-B39C-3DD9D1354B98Q57175255-306EE557-1648-42FA-8273-CDFCBD7C640D
P2860
Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening.
@ast
Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening.
@en
Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening.
@nl
type
label
Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening.
@ast
Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening.
@en
Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening.
@nl
prefLabel
Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening.
@ast
Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening.
@en
Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening.
@nl
P2093
P50
P356
P1476
Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening.
@en
P2093
Jean-Luc Galzi
Jean-Yves Springael
Muriel Hachet-Haas
P304
P356
10.1021/JM061389P
P407
P577
2007-02-21T00:00:00Z